Oriflame released its Interim Management Statement for the first nine months of 2026. The company continues to advance its growth and cash generation initiatives and has strengthened its data-driven decision making through enhanced customer and sales performance analytics. The company reported advancements in recruitment, activation and retention through simplified onboarding and a cost savings program that delivered further improvements on inventory levels and cash generation.
A transition to a digital-first commercial model is currently incorporating early market learnings to support successful adoption, and an AI-driven forecasting model is encouraging product portfolio optimization and supply chain transformation.
All regions reported lower year-over-year sales, with declines of 26% in Türkiye & Africa, 22% in Asia, 19% in Europe & CIS and 5% in Latin America. The company pointed to the termination of third-party sales from its Polish factory as a contributing factor in this decline. Adjusted EBITDA was -$1.6 million, which the company said reflected lower sales, but was partially offset by continued cost-control measures and lower marketing investments during the period.
The company ended the quarter with a cash balance of approximately $25.9 million.
